Lantheus Holdings, Inc.

LNTH

$100.98

+0.17%

N/A+$0.17

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their ...

Key Metrics of LNTH

Snapshot

Latest / TTM · 6 periods

Market Cap

$6.57B

ROCE

14.5%

EV / EBITDA

14.19x

-1.9% YoY

FCF Yield

7.8%

-0.1% YoY

Cash Conversion Cycle

88.3d

Current Ratio

3.06

Quick take

TTM —

Positive CCC

Key Metrics

Latest / TTM · 6 periods

Valuation trend

Valuation trend table

Metric	2021	2022	2023	2024	2025	TTM
Market CapTotal market value of all shares outstanding.	$1.95B	$3.49B	$4.23B	$6.19B	$4.49B	$6.57B
Enterprise ValueCompany value including debt and cash adjustments.	$2.04B	$3.66B	$4.14B	$5.90B	$4.75B	$6.61B
EV / SalesHow many dollars investors pay per dollar of sales.	4.80x	3.91x	3.19x	3.84x	3.08x	4.24x
EV / EBITDAValuation multiple versus operating earnings before non-cash charges.	-81.71x	44.70x	8.42x	11.44x	11.77x	14.19x
Net Debt / EBITDALeverage ratio using net debt divided by EBITDA.	-3.71	2.05	-0.20	-0.57	0.64	0.07

Returns + ROCE gauge

ROCE latest

14.5%

Prev year 16.4%

Returns + ROCE gauge table

Metric	2021	2022	2023	2024	2025	TTM
ROEProfit generated from shareholders' equity.	-15.3%	6.3%	40.0%	28.7%	21.4%	23.3%
ROAProfit generated from total assets.	-8.3%	2.1%	19.8%	15.8%	10.5%	11.4%
ROICReturn generated on invested operating capital.	-9.4%	3.8%	26.3%	21.5%	14.7%	16.4%
ROCEOperating return on long-term capital used.	-7.9%	3.4%	24.9%	26.3%	16.4%	14.5%
Earnings YieldEarnings as a percentage of market value.	-3.7%	0.8%	7.7%	5.0%	5.2%	4.2%

Cash flow quality

Cash flow quality table

Metric	2021	2022	2023	2024	2025	TTM
FCFFCash flow available to all capital providers.	$49.14M	$270.98M	$274.62M	$479.38M	$363.34M	$519.34M
FCFECash flow available to equity holders after debt flows.	$-1.57M	$645.80M	$257.99M	$464.81M	$347.53M	$502.99M
FCF YieldFree cash flow divided by market capitalization.	2.1%	7.5%	6.1%	8.0%	7.9%	7.8%
Income QualityHow well accounting earnings are backed by cash flow.	-0.76	10.04	0.93	1.74	1.67	1.37
Capex / OCFShare of operating cash flow spent on capital expenditures.	22.5%	6.5%	15.3%	9.5%	9.3%	5.2%

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	TTM
DSOAverage days to collect cash from customers.	76.7d	83.3d	80.0d	76.4d	84.9d	82.8d
DIOAverage days inventory stays before being sold.	54.0d	36.6d	39.8d	45.5d	39.4d	33.9d
DPOAverage days the company takes to pay suppliers.	31.9d	21.2d	25.6d	23.1d	26.1d	28.3d
Operating CycleTime from buying inventory to collecting receivables.	130.7d	119.9d	119.9d	122.0d	124.3d	116.6d
Cash Conversion CycleNet days cash is tied in operations.	98.7d	98.7d	94.2d	98.8d	98.2d	88.3d

Snapshot

Latest / TTM: —

Market Cap

$6.57B

ROE

23.3%

FCF Yield

7.8%

Current Ratio

3.06

Supply Chain of LNTH

Upstream / Downstream / Proxies

Upstream

BWX Technologies, Inc.NYSE:BWXTCurium PharmaCardinal Health, Inc. (Nuclear Pharmacy Services)NYSE:CAHPharmaLogic Holdings Corp.SOFIE (Sofie Biosciences)FramatomeNordion (a Sotera Health company)NASDAQ:SHC

Downstream

Cardinal Health, Inc. (Nuclear Pharmacy Network)NYSE:CAHUnited Pharmacy Partners (UPPI)PHO Enterprises / Triad IsotopesNovartis AG (Advanced Accelerator Applications)NYSE:NVS Perspective Therapeutics, Inc.NYSE:CATX GE HealthCare Technologies Inc.NASDAQ:GEHCSiemens Healthineers AGXETRA:SHLMayo ClinicVA Hospitals / US Department of Veterans Affairs

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer